Prime Medicine, Inc. To Start Trading Tomorrow

Prime Medicine, Inc. PRME IPO will take place October, 20 on the NASDAQ exchange under the ticker PRME.

The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on April 18, 2023.

See also: Benzinga IPO Calendar

About Prime Medicine, Inc.

Prime Medicine, Inc is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies to address the widest spectrum of diseases by deploying our Prime Editing technology, which we believe is a versatile, precise, efficient and broad gene editing technology

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.